• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH IH-500

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD MEDICAL DIAGNOSTICS GMBH IH-500 Back to Search Results
Catalog Number 001510
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Defective Device (2588)
Patient Problem Test Result (2695)
Event Date 01/23/2020
Event Type  malfunction  
Manufacturer Narrative
This is our initial report on this incident.
 
Event Description
The customer reported abo blood group discrepancies of three samples when tested using ih-card abo/d(dvi-)+rev.A1, b on ih-500: issue 1- the customer ran an abo/d determination along with the abo blood group confirmation of a control reagent.The blood group was a negative but the abo blood group confirmation was typed as an blood group ab.The customer reran the abo blood group confirmation and it was typed as an a negative.Issue 2- the customer ran 3 patients samples.The customer confirmed there were two patient samples with blood group a rh(d) positive that were performed before the third patient.The third patient had a history of typing as an blood group o rh(d) positive.The sample was forward typed as an blood group a rh(d) positive and reverse typed as a blood group o.The customer performed a manual tube test and the sample resulted as blood group o rh(d) positive.Issue 3- the customer ran another patient on the ih-500 that was forward typed as a blood group b rh(d) positive but reversed typed as a blood group o.The customer performed a manual tube test and the sample resulted as blood group b rh(d) positive.The customer did neither return the supposedly defective product ih-card abo/d(dvi-)+rev.A1, b for investigational testing nor the patient samples that had caused false positive test results.Therefore our quality control laboratory tested their retention sample of ih-card abo/d(dvi-)+rev.A1, b on ih-500.The testing is still ongoing.Furthermore we are still waiting for the requested files of ih-500 in order to investigate them.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lot.
 
Event Description
The customer reported abo blood group discrepancies of three samples when tested using ih-card abo/d(dvi-)+rev.A1, b on ih-500: issue 1- the customer ran an abo/d determination along with the abo blood group confirmation of a control reagent.The blood group was a negative but the abo blood group confirmation was typed as an blood group ab.The customer reran the abo blood group confirmation and it was typed as an a negative.Issue 2- the customer ran 3 patients samples.The customer confirmed there were two patient samples with blood group a rh(d) positive that were performed before the third patient.The third patient had a history of typing as an blood group o rh(d) positive.The sample was forward typed as an blood group a rh(d) positive and reverse typed as a blood group o.The customer performed a manual tube test and the sample resulted as blood group o rh(d) positive.Issue 3- the customer ran another patient on the ih-500 that was forward typed as a blood group b rh(d) positive but reversed typed as a blood group o.The customer performed a manual tube test and the sample resulted as blood group b rh(d) positive.The customer did neither return the supposedly defective product ih-card abo/d(dvi-)+rev.A1, b for investigational testing nor the patient samples that had caused false positive test results.Therefore our quality control laboratory tested their retention sample of ih-card abo/d(dvi-)+rev.A1, b on the ih-500: seven donor samples (2 x a1, 1 x o, 3 x b and 1 x a1, b) were tested.All positive and negative reactions were correct.Additionally the retention sample was visually checked for visible supernatant, intact sealing and homogeneous gel.All acceptance criteria were met.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lot.The affected ih-500 was inspected by our field service engineers.The issue was found to be related with a hardware issue.It was detected that there was an issue regarding the connection to the sodium hydroxide was not connected correctly and the instrument was not drawing the sodium hydroxide properly.After the intervention of the field service engineer the problem was resolved and we have obtained the confirmation that issues were resolved.Our initial report was issued for ih-card abo/d(dvi-)+rev.A1, b.Since it turned out that the problem was related to the customer's ih-500, our final report is issued for the ih-500.
 
Manufacturer Narrative
This is our final report on this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IH-500
Type of Device
IH-500
Manufacturer (Section D)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, 63303
GM  63303
MDR Report Key9726463
MDR Text Key204775927
Report Number9610824-2020-00005
Device Sequence Number1
Product Code KSZ
UDI-Device Identifier07611969964529
UDI-Public(01)07611969964529(17)201220(10)8934020
Combination Product (y/n)N
PMA/PMN Number
BK180274
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 04/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/19/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/20/2020
Device Catalogue Number001510
Device Lot Number8934020
Was Device Available for Evaluation? Yes
Date Manufacturer Received01/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
IH 1000, # 5100018; IH 1000, # 5100018; IH CARD AHG ANTI-IGG, LOT 8933060; IH CARD AHG ANTI-IGG, LOT 8933060; IH-CARD ABO/D(DVI-)+REV A1,B, LOT 8934020; IH-CELL A1&B, LOT 8950011; IH-CELL A1&B, LOT 8950011; IH-CELL I-II-III, LOT 8950011; IH-CELL I-II-III, LOT 8950011
-
-